REBOOT-CNIC: Beta-Blockers Show No Benefit Post-MI in Patients with Preserved Ejection Fraction

RELAXIN-LA Trial: Volenrelaxin Linked to Worsening Congestion in HFpEF

High-Dose Flu Vaccine Linked to Reduced Cardiovascular Hospitalisations in Older Adults

Mavacamten Fails to Meet Primary Endpoints in Non-obstructive Hypertrophic Cardiomyopathy

Simple Risk Stratification Could Optimise Heart Failure Follow-Up and Outcomes

Diagnostic Red Flags are Common in Hypertrophic Cardiomyopathy, Study Finds

Heart Failure's Global Economic Toll Exceeds $284 Billion, New Study Finds

FDA Approves Finerenone for Heart Failure with LVEF ≥40%

Time in Target Ambulatory Blood Pressure Range Linked to Lower CV Risk

ESC Scientific Statement: Extreme Heat Poses Significant Cardiovascular Risk